Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06514313 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06514313 · ClinicalTrials.gov record · last posted 2024-07-23

Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

Name: Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. — clinical trial record (NCT06514313)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorYizhuo Zhang

Started2024-07-03

View on ClinicalTrials.gov ↗

Record status

This record was last updated July 23, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

Explore the efficacy and safety of mitoxantrone liposome combined with irinotecan and vincristine (VIM) in the treatment of relapsed/refractory soft tissue sarcoma in children.

Trial Details

NCT Number	NCT06514313
Lead Sponsor	Yizhuo Zhang
Conditions	Soft Tissue Sarcoma
Enrollment	110 participants
Start Date	2024-07-03
Primary Completion	2026-08-01 (estimated)
Study Completion	2026-12-01 (estimated)
Updated on ClinicalTrials.gov	2024-07-23